Fast Five Quiz: Painful Sexual Intercourse

Bradley Schwartz, DO; Michel E. Rivlin, MD


May 21, 2021

Mindfulness-based interventions have been shown to effectively treat low sexual desire and arousal and acquired anorgasmia.

Because FSIAD may be a side effect of medications, a frequent solution is adjustment of other prescriptions. Although a host of pharmaceuticals have been implicated in affecting sexual desire and arousal (including antihistamines, beta-blockers, diuretics, and hormonal contraceptives), the most common culprits are SSRI antidepressants. Bupropion in higher dosages (150 mg twice daily) is often effective as an adjunct for antidepressant-related FSIAD.

One medication that is approved by the US Food and Drug Administration to treat FSIAD is flibanserin, a 5-HT1A/2B agonist/antagonist. It is indicated for premenopausal women with low sexual desire. It is taken nightly and requires daily use. Due to the risk for syncope and hypotension, use of alcohol is prohibited for women on this medication.

Read more information about the treatment of FSIAD.

This Fast Five Quiz was excerpted and adapted from the Medscape Drugs & Diseases articles Gynecologic Pain, Peyronie Disease, Vulvovaginitis, Penile Fracture, and Female Sexual Dysfunction.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube.